γ-Cyclodextrin hydrogel for the sustained release of josamycin for potential ocular application

• Päätekijät: Jennifer Huling (Tekijä), Stefan Oschatz (Tekijä), Helge Lange (Tekijä), Katharina Anna Sterenczak (Tekijä), Thomas Stahnke (Tekijä), Jana Markhoff (Tekijä), Oliver Stachs (Tekijä), Steffen Möller (Tekijä), Nasrullah Undre (Tekijä), Anita Peil (Tekijä), Anselm Jünemann (Tekijä), Niels Grabow (Tekijä), Georg Fuellen (Tekijä), Thomas Eickner (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Glaucoma is the leading cause of blindness worldwide. However, its surgical treatment, in particular via trabeculectomy, can be complicated by fibrosis. In current clinical practice, application of the drug, Mitomycin C, prevents or delays fibrosis, but can lead to additional side effects, such as b...